Introduction
In recent years, the biotechnology field has witnessed unprecedented growth, driven by technological advancement, market demand, and perhaps most crucially, government support and funding. Recombinant Human Neuregulin (rhNRG), a promising biopharmaceutical intervention, represents a pinnacle of this progress, offering hope for various medical conditions. The synergy between scientific innovation and governmental backing is catalyzing this evolution, amplifying efforts t
...
Read more »